Skip to main content
Erschienen in: Critical Care 1/2015

Open Access 01.12.2015 | Letter

Importance of a registered and structured protocol when conducting systematic reviews: comments about nebulized antibiotics for ventilator-associated pneumonia

verfasst von: Fernando G. Zampieri, Antonio P. Nassar Jr, Dimitri Gusmao-Flores, Leandro U. Taniguchi, Antoni Torres, Otavio T. Ranzani

Erschienen in: Critical Care | Ausgabe 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise

Competing interests

The authors declare that they have no competing interests.

Author contributions

FGZ conceived the study, participated in data acquisition, data analysis, and interpretation, and helped to revise the manuscript for important intellectual content. APN participated in conception of the study, data acquisition, data analysis, and interpretation, and helped to revise the manuscript for important intellectual content. DG-F participated in conception of the study and interpretation, and helped to revise the manuscript for important intellectual content. LUT participated in conception and design of the study and interpretation, and helped to revise the manuscript for important intellectual content. AT participated in conception and design of the study and interpretation, and helped to revise the manuscript for important intellectual content. OTR conceived the design of the study, participated in data acquisition and interpretation, and wrote the draft of the manuscript. All authors read and approved the final manuscript.
Abkürzungen
CI
Confidence interval
LOS
Length of stay
OR
Odds ratio
SMD
Standardized mean difference
VAP
Ventilator-associated pneumonia
We appreciate Gu’s [1] interest in our study. We apologize and agree with his comment about attributing units to standardized mean difference (SMD). Nevertheless, similar to the SMD, results in mean difference (control – nebulized) were unaffected by nebulized antibiotics (2.67 days, 95 % confidence interval (CI) –2.89, 8.23 for ICU length of stay (LOS); and 0.70 days, 95 % CI −3.40, 4.80 for mechanical ventilation). However, we strongly disagree with other points raised by the letter.
First, the study protocol was defined a priori [2]. We disagree that combining observational studies with intervention studies is reserved only for safety evaluation. This topic has been discussed in the literature and combining both types of studies was adequate for our aim [3]. Furthermore, we presented the main results separating interventional studies from observational studies, thereby allowing the reader to interpret both analyses independently.
Second, both of the studies cited as “case–control studies” [1] received this denomination in their title and abstract. However, by reading their methods it becomes clear that they are actually matched cohort studies [4, 5]. Indeed, they matched exposed patients (“nebulized group”) to unexposed patients (“no-nebulized group”). A case–control design starts with the outcome (case = “clinical success”) and matches them with controls (“clinical failures”). Therefore, our measure of effect was correct [5]. For exploration, we report the analysis for clinical cure using the odds ratio (OR) (Fig. 1). The results are unchanged.
Third, Kalin’s study was included because it fulfilled our inclusion/exclusion criteria [2]. Gu’s suggestion to exclude this study based solely on its effects in heterogeneity could be considered selective reporting [1].
Our study provided data for further trials aiming to evaluate the effect of nebulized antibiotics in ventilator-associated pneumonia (VAP) [2].
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Author contributions

FGZ conceived the study, participated in data acquisition, data analysis, and interpretation, and helped to revise the manuscript for important intellectual content. APN participated in conception of the study, data acquisition, data analysis, and interpretation, and helped to revise the manuscript for important intellectual content. DG-F participated in conception of the study and interpretation, and helped to revise the manuscript for important intellectual content. LUT participated in conception and design of the study and interpretation, and helped to revise the manuscript for important intellectual content. AT participated in conception and design of the study and interpretation, and helped to revise the manuscript for important intellectual content. OTR conceived the design of the study, participated in data acquisition and interpretation, and wrote the draft of the manuscript. All authors read and approved the final manuscript.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Gu WJ. Nebulized antibiotics for ventilator-associated pneumonia: misleading analysis and interpretation of the data. Crit Care. 2015;19:236.CrossRef Gu WJ. Nebulized antibiotics for ventilator-associated pneumonia: misleading analysis and interpretation of the data. Crit Care. 2015;19:236.CrossRef
2.
Zurück zum Zitat Zampieri FG, Nassar AP, Gusmao-Flores D, Taniguchi LU, Torres A, Ranzani OT. Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care. 2015;19:150.CrossRef Zampieri FG, Nassar AP, Gusmao-Flores D, Taniguchi LU, Torres A, Ranzani OT. Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care. 2015;19:150.CrossRef
3.
Zurück zum Zitat Shrier I, Boivin JF, Steele RJ, Platt RW, Furlan A, Kakuma R, et al. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am J Epidemiol. 2007;166:1203–9.CrossRef Shrier I, Boivin JF, Steele RJ, Platt RW, Furlan A, Kakuma R, et al. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am J Epidemiol. 2007;166:1203–9.CrossRef
4.
Zurück zum Zitat Cummings P, McKnight B, Greenland S. Matched cohort methods for injury research. Epidemiol Rev. 2003;25:43–50.CrossRef Cummings P, McKnight B, Greenland S. Matched cohort methods for injury research. Epidemiol Rev. 2003;25:43–50.CrossRef
5.
Zurück zum Zitat Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
Metadaten
Titel
Importance of a registered and structured protocol when conducting systematic reviews: comments about nebulized antibiotics for ventilator-associated pneumonia
verfasst von
Fernando G. Zampieri
Antonio P. Nassar Jr
Dimitri Gusmao-Flores
Leandro U. Taniguchi
Antoni Torres
Otavio T. Ranzani
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 1/2015
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-015-1020-8

Weitere Artikel der Ausgabe 1/2015

Critical Care 1/2015 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.